The 13th international Workshop on KSHV and Related Agents

描述（由申请人提供）：第13届卡波西肉瘤相关疱疹病毒（KSHV）和相关因子国际研讨会自1998年以来每年举行一次。该研讨会是介绍和交流KSHV和相关制剂进展的主要论坛。特别强调的一直是对未发表的新数据的介绍和讨论，目的是促进新的研究成果，想法和发展的传播和交流的国际科学家代表基础，转化和临床研究谁涵盖了广泛的学科，并侧重于KSHV和相关代理。这些研究的长期目标是提高我们对KSHV和相关因子如何促进发病机制的理解，并将来自不同研究领域的新知识整合到新的治疗，预防和疫苗接种策略的识别和开发中，以减轻KSHV相关疾病。 本次研讨会将由加州大学洛杉矶分校（UCLA）和加州纳米系统研究所（CNSI）主办，并将于2010年8月29日至9月1日在CNSI在加州大学洛杉矶分校校园内或加州大学洛杉矶分校韦斯特伍德村住宿。会议的其余费用将从与会者支付的登记费和基金会、商业、制药和生物技术公司的捐款中收回。 研讨会的科学计划将由15分钟的演讲（10-12分钟的演讲，3分钟的问答）组成，这些演讲选自九个科学会议（临床应用，细胞信号传导，流行病学，基因表达，宿主相互作用，潜伏期，裂解复制和结构，病毒发病机制）中的科学演讲摘要。在研讨会结束时，也有时间分配给后期突破者摘要和圆桌讨论。预计在为期4天的会议期间将有大约74个平台介绍和多达60个海报。 公共卫生相关性：该提案要求为一次年度会议（自1998年以来举行）提供部分资金，在该会议上介绍和交流关于KSHV和相关制剂的研究进展，从而促进相关疾病的预防和治疗。

DESCRIPTION (provided by applicant): The 13th International Workshop on Kaposi's Sarcoma-Associated Herpesvirus (KSHV) and Related Agents has been held annually since 1998. This workshop is the premier forum for the presentation and exchange of advances in KSHV and related agents. Special emphasis has always been on the presentation and discussion of unpublished new data with the goal to facilitate the dissemination and exchange of new research findings, ideas, and developments among an international group of scientists representing basic, translational, and clinical research who cover a broad spectrum of disciplines and focus on KSHV and related agents. The long-term goal of these studies is to enhance our understanding on how KSHV and related agents contribute to pathogenesis and to integrate this new knowledge from different research fields into the identification and development of new treatment, prevention, and vaccination strategies to alleviate KSHV associated diseases. This workshop will be hosted by the University of California, Los Angeles (UCLA) and the California NanoSystems Institute (CNSI), and will be held August 29- September 1, 2010 at CNSI on the UCLA campus with housing accommodations on campus or within the UCLA Westwood Village. The remaining costs for this conference will be recovered from registration fees paid by conferees and contributions from foundations, and commercial, pharmaceutical and biotechnology companies. The Scientific Program of the workshop will be composed of 15 minute presentations (10-12 minute talks with 3 minutes for questions/answers) chosen from abstracts submitted for scientific presentations in each of the nine Scientific Sessions (Clinical applications, Cell signaling, Epidemiology, Gene expression, Host Interactions, Latency, Lytic Replication and Structure, Viral Pathogenesis). There is also time allotted at the end of the workshop for Late Breaker abstracts and Roundtable Discussion. It is anticipated that there will be approximately 74 platform presentations and up to 60 posters presented during this 4 day meeting. PUBLIC HEALTH RELEVANCE: This proposal requests partial funding for an annual meeting (held since 1998) where there are presentations and exchange of advances in research on KSHV and related agents, thereby promote the prevention and therapy of the related diseases.